Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.05 USD | -0.96% | -10.87% | -69.08% |
03/05 | Aditxt, Inc. announced that it expects to receive $4.2 million in funding | CI |
02/05 | Aditxt, Inc. announced that it expects to receive $150 million in funding | CI |
Business Summary
Number of employees: 47
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immune Reprogramming Technologies
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -30.90% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -30.90% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 61 | 28/17/28 | |
Amro Albanna
CEO | Chief Executive Officer | 54 | 28/17/28 |
Thomas Farley
DFI | Director of Finance/CFO | 51 | 01/20/01 |
Rowena Albanna
COO | Chief Operating Officer | 58 | 10/20/10 |
Jennifer Lee
HRO | Human Resources Officer | - | 01/21/01 |
Dolly B. Tyan
PRN | Corporate Officer/Principal | - | 29/21/29 |
Corporate Officer/Principal | 57 | 02/20/02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Runge
BRD | Director/Board Member | 67 | 10/20/10 |
Amro Albanna
CEO | Chief Executive Officer | 54 | 28/17/28 |
Founder | 61 | 28/17/28 | |
Brian Brady
BRD | Director/Board Member | 46 | 01/18/01 |
Charles Nelson
BRD | Director/Board Member | 71 | 03/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,665,265 | 1,623,690 ( 97.50 %) | 51 ( 0.003063 %) | 97.50 % |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-69.08% | 3.45M | |
+3.01% | 108B | |
+11.17% | 104B | |
+1.75% | 22.33B | |
-12.04% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.36% | 17.64B | |
+5.84% | 14.05B | |
+34.91% | 12.51B |
- Stock Market
- Equities
- ADTX Stock
- Company Aditxt, Inc.